Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Sands China’s Cotai Strip® development was beautifully aflame in celebration Thursday evening, as the integrated resort city introduced to Macao the latest additions at Sands® Cotai Central, led by the launch of Sheraton Macao Hotel, Cotai Central, which has the double distinction of being the largest hotel for both Macao and Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT).
To view Multimedia News Release, go to http://www.multivu.com/mnr/58010-sands-cotai-central-celebrates-second-phase-opening
Royal Caribbean Cruises Ltd. (NYSE: RCL) today announced an agreement with Miami-Dade County to construct and operate a dramatic new cruise terminal at PortMiami, on land leased from the County. The new terminal will be a striking addition to PortMiami, and will serve as homeport to Royal Caribbean International ships, including a 5,400-passenger Oasis-class ship, the world’s largest and most innovative cruise ships. The agreement will come before the Miami-Dade County Board of County Commissioners on July 6, 2016.
“We are truly excited to be working with Miami-Dade County and PortMiami to create not just another cruise terminal, but a truly iconic building,” said Richard Fain, chairman and CEO for Royal Caribbean Cruises Ltd. “This new terminal is a symbol of our commitment to Miami, the city where our company first started almost 50 years ago. We can’t wait to bring an Oasis-class ship to PortMiami.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7657052-royal-caribbean-miami-dade-cruise-terminal/
Corporate Executive Board (CEB) (NYSE: EXBD), a leading research and advisory services firm, today announced the release of “The Challenger Sale: Taking Control of the Customer Conversation,” a new book that confirms companies are wasting precious time and money cultivating sales people who focus on building and maintaining relationships instead of teaching business insights—the number one attribute customers value in today’s complex selling environment. “The Challenger Sale” prescribes specific steps companies can take to develop a sales force of Challengers, which in a study of more than 6,000 sales reps, consistently outperformed other types of sales reps by nearly 15 percent.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52980-corporate-executive-board-new-book-the-challenger-sale-dixon-adamson
Elephant seals equipped with antennas on their heads to map the oceans; satellites being used to target mosquitoes; an SMS system preventing the sale of counterfeit medicines in Ghana; smartphones that can predict you’re going to get depressed; credit cards that know two years before you do that you’re headed toward divorce; pills that transmit information directly from your body to your physician.
These and other stories are being told through “The Human Face of Big Data,” the latest groundbreaking, globally crowdsourced initiative from Rick Smolan, the creator of the “Day in the Life” series. The project, made possible through primary sponsorship from EMC® (NYSE:EMC), is based on the premise that the real-time visualization of data collected by satellites, and by billions of sensors, RFID tags, and GPS-enabled cameras and smartphones around the world, is enabling humanity to sense, measure, understand and affect aspects of our existence in ways our ancestors could never have imagined in their wildest dreams.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58095-rick-smolan-human-face-of-big-data-project-globally-crowdsourced
Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, is simplifying the design, fitting and care of full-face masks for sleep apnea patients. With its unique modular design, the new Amara full-face mask further demonstrates Philips’ commitment to developing solutions aimed at improving care and outcomes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57117-philips-respironics-revolutionary-full-face-mask-sleep-therapy
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Raytheon Company (NYSE: RTN) unveiled its second generation Exoskeleton (XOS 2) at its research facility in Salt Lake City, Utah, during a demonstration with Paramount Home Entertainment. The new robotic suit is lighter, faster and stronger than its predecessor, yet it uses 50 percent less power. Its enhanced design also means that it is more resistant to the environment.
To view Multimedia NewsRelease, go to http://multivu.prnewswire.com/mnr/raytheon/46273/
Reinforcing its long-standing commitment to furthering math and science education globally, Raytheon Company (NYSE: RTN) is bringing its MathMovesU® initiative to the Gulf Region. Raytheon will premiere the regional expansion of MathMovesU — which is well established in the United States, Australia and Europe — with two key launches.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63761-raytheon-mathmovesu-education-launches-in-gulf-region
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
Procter & Gamble’s (NYSE: PG) PUR Water Filtration is introducing a new line-up of one-click faucet mount filtration systems that makes getting clean drinking water instantly from the tap easier and more convenient than ever before. The first and only faucet mount design that installs with one easy click, the new PUR faucet water filter offers up to 100 gallons of great-tasting drinking water with just one click. The new design is simple to install so that no tools are required and it can be easily disconnected when needed.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pur/45502/
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
